BACKGROUND Severe acute respiratory syndrome coronavirus-2(SARS-CoV-2)infection is a global pandemic that is associated with a high risk of morbidity and mortality among recipients of solid organ transplantation.In th...BACKGROUND Severe acute respiratory syndrome coronavirus-2(SARS-CoV-2)infection is a global pandemic that is associated with a high risk of morbidity and mortality among recipients of solid organ transplantation.In the course of acute SARS-CoV-2 infection,various laboratory markers have been identified as predictors for high risk of mortality.AIM To risk stratify renal transplant recipients(RTxR)using general demographic parameters,comorbidities and routine laboratory markers for the severity of the disease and its outcomes.We believe that learning about these routinely monitored parameters can help us plan better strategies for the RTxR follow-up program.METHODS This present study includes RTxR who acquired SARS-CoV-2 infection from March 2020 to February 2021.We recorded the basic demographics,comorbidities and routine laboratory markers.We investigated the impact of SARS-CoV-2 infection on RTxRs and risk-stratified the progression of disease severity and outcomes in terms of recovery or mortality.RESULTS From 505 RTxRs in our renal transplant follow-up program,29(7.75%)RTxRs had PCR-positive SARS-CoV-2 infection.We recorded 8 deaths from SARS-CoV-2 infection giving an overall mortality rate of 1.6%but a significant 27.6%mortality in SARS-CoV-2 positive recipients.Age more than 68 years,non-Caucasian ethnicity and male gender were associated with a significant drop in survival probability;P≤0.001.<0.001 and<0.0001 respectively.87.5%of the deceased were diabetic;P≤0.0.0001.Estimated glomerular filtration rate of less than 26 mL/min/1.73 m2,serum albumin less than 20 g/L,Hemoglobin less than 9.6 g/L and serum calcium less than 1.70 mmol/L were all associated with significantly increased risk of mortality;P=0.0128,<0.001,<0.0001 and 0.0061 respectively.CONCLUSION This study has identified some routinely used modifiable parameters in predicting a higher risk of mortality and morbidity.This knowledge can be used in RTxR follow-up programs by addressing these parameters early to help reduce the morbidity and mortality in RTxRs.展开更多
<p style="text-align:justify;"> <span>Following organ transplantation</span><span>,</span><span> the outcome of the encounter between an APC and a T lymphocyte is str...<p style="text-align:justify;"> <span>Following organ transplantation</span><span>,</span><span> the outcome of the encounter between an APC and a T lymphocyte is strongly dependent on the presence of costimulatory and co-inhibitory molecules, the former associated with allograft rejection and the latter with allograft acceptance. We evaluated the expression of PD-L2, GITR, ILT-2/3/5, and ILT-4 on graft-infiltrating cells procured by Fnab from human KTx under different immunosuppressive regimens. Methods: Fnab biopsies were performed on days 7 or 14</span><span> </span><span>-</span><span> </span><span>30 in stable KTx and on the day of acute rejection diagnosis. Cytopreparations were studied by the enzymatic avidin biotin complex staining. Results: Acute rejection group </span><span>showed a significant down-regulated expression of PD-L2, GITR, and ILT-2/3/5 </span><span>as compared to stable group, while for ILT-4 we did not find significant difference. Anti-IL2</span><i><span>α</span></i><span>R and rapamicyn treatment trend to down-regulate ILT-4 expression, although meaningless. A significant</span><span>ly</span><span> positive correlation was observed between PD-L2 and GITR expression in Fnab. The PPV for acute rejection diagnosis for both PD-L2 and GITR w</span><span>as</span><span> clearly above 0.8. Conclusions: Our findings point to an early entrance of cells expressing PD-L2, GITR and ILT-2/3/5 inside human KTx who are going to remain rejection-free. Both PD-L2 and GITR shared a high ability to rule-in and rule-out acute rejection.</span> </p>展开更多
In the present study, we transplanted adipose-derived mesenchymal stem cells into the hippo-campi of APP/PS1 transgenic Alzheimer＇s disease model mice. Immunofluorescence staining revealed that the number of newly ge...In the present study, we transplanted adipose-derived mesenchymal stem cells into the hippo-campi of APP/PS1 transgenic Alzheimer＇s disease model mice. Immunofluorescence staining revealed that the number of newly generated （BrdU＋） cells in the subgranular zone of the dentate gyrus in the hippocampus was signiifcantly higher in Alzheimer＇s disease mice after adipose-de-rived mesenchymal stem cell transplantation, and there was also a significant increase in the number of BrdU＋/DCX＋neuroblasts in these animals. Adipose-derived mesenchymal stem cell transplantation enhanced neurogenic activity in the subventricular zone as well. Furthermore, adipose-derived mesenchymal stem cell transplantation reduced oxidative stress and alleviated cognitive impairment in the mice. Based on these ifndings, we propose that adipose-derived mes-enchymal stem cell transplantation enhances endogenous neurogenesis in both the subgranular and subventricular zones in APP/PS1 transgenic Alzheimer＇s disease mice, thereby facilitating functional recovery.展开更多
目的探讨免疫检查点抑制剂(Immune checkpoint inhibitors,ICIs)在肾移植后恶性肿瘤患者中的安全性和有效性,为上述患者使用ICIs提供参考。方法检索中国知网、维普、万方、PubMed以及Web of Science数据库,收集至2022年12月关于ICIs在...目的探讨免疫检查点抑制剂(Immune checkpoint inhibitors,ICIs)在肾移植后恶性肿瘤患者中的安全性和有效性,为上述患者使用ICIs提供参考。方法检索中国知网、维普、万方、PubMed以及Web of Science数据库,收集至2022年12月关于ICIs在肾移植后恶性肿瘤患者中应用的文献,提取数据并整理分析。结果纳入分析的患者,平均年龄为64.58岁,其中男21例,女10例;恶性肿瘤的诊断时间与最后一次肾移植时间的平均跨度为9.67年;免疫抑制剂有完整使用记录的患者中约一半在使用ICIs后对药物进行了调整,多数为减少免疫抑制剂的种类;患者肿瘤诊断主要为黑色素瘤,次之为皮肤鳞状细胞癌;使用ICIs类型包括程序性死亡受体-1(programmed cell death protein 1,PD-1)抑制剂,程序性死亡配体-1(programmed cell death-1 ligand-1,PD-L1)抑制剂和细胞毒性T淋巴细胞相关抗原-4(cytotoxic T lymphocyte-associated antigen-4,CTLA-4)抑制剂,ICIs在肾移植后恶性肿瘤患者中的疾病控制率为55.17%;发生排斥的10例患者,经处理后,最终5例丢失移植物。结论ICIs可能给部分肾移植后恶性肿瘤患者带来临床获益,但也可能诱发患者发生排斥反应,因此,肾移植后恶性肿瘤患者使用ICIs需充分考虑获益风险比。展开更多
背景:冻存能够较好地保证血管结构的完整性,如何改善移植后排斥反应的问题受到越来越多的关注。目的:综述不同冷冻技术降低同种异体血管移植排斥反应的研究进展,以期为临床研究提供参考。方法:系统检索中英文数据库CNKI、万方和PubMed...背景:冻存能够较好地保证血管结构的完整性,如何改善移植后排斥反应的问题受到越来越多的关注。目的:综述不同冷冻技术降低同种异体血管移植排斥反应的研究进展,以期为临床研究提供参考。方法:系统检索中英文数据库CNKI、万方和PubMed以及在线网站Baidu和Google Scholar自建库以来发表的降低同种异体血管移植排斥反应的相关文献。中文检索关键词:心血管疾病、内皮细胞、低温冻存、血管移植、免疫原性、排斥反应,同种异体移植和冷冻保护剂;英文检索关键词:cardiovascular disease、endothelial cells、cryopreservation、blood vessel transplantation or vascular graft、Immunogenicity、immune rejection、allograft or allogeneic transplantation or allograft transplantation and cryoprotectant。按照纳入排除标准共选取68篇文献进行综述。结果与结论:①综述发现通过改进现有冷冻技术能够降低同种异体血管移植排斥反应,其中主要涉及冻融方式和冻存保护剂的选择。②现有研究提示冻干法优于低温冻存,但限于条件未能广泛开展,现仍以低温冻存为主,其中玻璃化冻存、缓慢复温和使用不锈钢乃至含银材料效果优于程序式冻存及快速复温。③渗透性和非渗透性冻存保护剂的联合选择,可以在降低其毒性的同时,进一步减少排斥反应的发生。展开更多
基金Compliance with local ethical and data protection policies.Registered with St Georges University Hospitals NHS Foundation Trust Quality Assurance Department.Registration no AUD1000854。
文摘BACKGROUND Severe acute respiratory syndrome coronavirus-2(SARS-CoV-2)infection is a global pandemic that is associated with a high risk of morbidity and mortality among recipients of solid organ transplantation.In the course of acute SARS-CoV-2 infection,various laboratory markers have been identified as predictors for high risk of mortality.AIM To risk stratify renal transplant recipients(RTxR)using general demographic parameters,comorbidities and routine laboratory markers for the severity of the disease and its outcomes.We believe that learning about these routinely monitored parameters can help us plan better strategies for the RTxR follow-up program.METHODS This present study includes RTxR who acquired SARS-CoV-2 infection from March 2020 to February 2021.We recorded the basic demographics,comorbidities and routine laboratory markers.We investigated the impact of SARS-CoV-2 infection on RTxRs and risk-stratified the progression of disease severity and outcomes in terms of recovery or mortality.RESULTS From 505 RTxRs in our renal transplant follow-up program,29(7.75%)RTxRs had PCR-positive SARS-CoV-2 infection.We recorded 8 deaths from SARS-CoV-2 infection giving an overall mortality rate of 1.6%but a significant 27.6%mortality in SARS-CoV-2 positive recipients.Age more than 68 years,non-Caucasian ethnicity and male gender were associated with a significant drop in survival probability;P≤0.001.<0.001 and<0.0001 respectively.87.5%of the deceased were diabetic;P≤0.0.0001.Estimated glomerular filtration rate of less than 26 mL/min/1.73 m2,serum albumin less than 20 g/L,Hemoglobin less than 9.6 g/L and serum calcium less than 1.70 mmol/L were all associated with significantly increased risk of mortality;P=0.0128,<0.001,<0.0001 and 0.0061 respectively.CONCLUSION This study has identified some routinely used modifiable parameters in predicting a higher risk of mortality and morbidity.This knowledge can be used in RTxR follow-up programs by addressing these parameters early to help reduce the morbidity and mortality in RTxRs.
文摘<p style="text-align:justify;"> <span>Following organ transplantation</span><span>,</span><span> the outcome of the encounter between an APC and a T lymphocyte is strongly dependent on the presence of costimulatory and co-inhibitory molecules, the former associated with allograft rejection and the latter with allograft acceptance. We evaluated the expression of PD-L2, GITR, ILT-2/3/5, and ILT-4 on graft-infiltrating cells procured by Fnab from human KTx under different immunosuppressive regimens. Methods: Fnab biopsies were performed on days 7 or 14</span><span> </span><span>-</span><span> </span><span>30 in stable KTx and on the day of acute rejection diagnosis. Cytopreparations were studied by the enzymatic avidin biotin complex staining. Results: Acute rejection group </span><span>showed a significant down-regulated expression of PD-L2, GITR, and ILT-2/3/5 </span><span>as compared to stable group, while for ILT-4 we did not find significant difference. Anti-IL2</span><i><span>α</span></i><span>R and rapamicyn treatment trend to down-regulate ILT-4 expression, although meaningless. A significant</span><span>ly</span><span> positive correlation was observed between PD-L2 and GITR expression in Fnab. The PPV for acute rejection diagnosis for both PD-L2 and GITR w</span><span>as</span><span> clearly above 0.8. Conclusions: Our findings point to an early entrance of cells expressing PD-L2, GITR and ILT-2/3/5 inside human KTx who are going to remain rejection-free. Both PD-L2 and GITR shared a high ability to rule-in and rule-out acute rejection.</span> </p>
基金supported by the National High-Tech Research and Development Program of China(863 Program),No.2012AA020905Tsinghua-Yue-Yuen Medical Sciences Fund,No.20240000514
文摘In the present study, we transplanted adipose-derived mesenchymal stem cells into the hippo-campi of APP/PS1 transgenic Alzheimer＇s disease model mice. Immunofluorescence staining revealed that the number of newly generated （BrdU＋） cells in the subgranular zone of the dentate gyrus in the hippocampus was signiifcantly higher in Alzheimer＇s disease mice after adipose-de-rived mesenchymal stem cell transplantation, and there was also a significant increase in the number of BrdU＋/DCX＋neuroblasts in these animals. Adipose-derived mesenchymal stem cell transplantation enhanced neurogenic activity in the subventricular zone as well. Furthermore, adipose-derived mesenchymal stem cell transplantation reduced oxidative stress and alleviated cognitive impairment in the mice. Based on these ifndings, we propose that adipose-derived mes-enchymal stem cell transplantation enhances endogenous neurogenesis in both the subgranular and subventricular zones in APP/PS1 transgenic Alzheimer＇s disease mice, thereby facilitating functional recovery.
文摘目的探讨免疫检查点抑制剂(Immune checkpoint inhibitors,ICIs)在肾移植后恶性肿瘤患者中的安全性和有效性,为上述患者使用ICIs提供参考。方法检索中国知网、维普、万方、PubMed以及Web of Science数据库,收集至2022年12月关于ICIs在肾移植后恶性肿瘤患者中应用的文献,提取数据并整理分析。结果纳入分析的患者,平均年龄为64.58岁,其中男21例,女10例;恶性肿瘤的诊断时间与最后一次肾移植时间的平均跨度为9.67年;免疫抑制剂有完整使用记录的患者中约一半在使用ICIs后对药物进行了调整,多数为减少免疫抑制剂的种类;患者肿瘤诊断主要为黑色素瘤,次之为皮肤鳞状细胞癌;使用ICIs类型包括程序性死亡受体-1(programmed cell death protein 1,PD-1)抑制剂,程序性死亡配体-1(programmed cell death-1 ligand-1,PD-L1)抑制剂和细胞毒性T淋巴细胞相关抗原-4(cytotoxic T lymphocyte-associated antigen-4,CTLA-4)抑制剂,ICIs在肾移植后恶性肿瘤患者中的疾病控制率为55.17%;发生排斥的10例患者,经处理后,最终5例丢失移植物。结论ICIs可能给部分肾移植后恶性肿瘤患者带来临床获益,但也可能诱发患者发生排斥反应,因此,肾移植后恶性肿瘤患者使用ICIs需充分考虑获益风险比。
文摘背景:冻存能够较好地保证血管结构的完整性,如何改善移植后排斥反应的问题受到越来越多的关注。目的:综述不同冷冻技术降低同种异体血管移植排斥反应的研究进展,以期为临床研究提供参考。方法:系统检索中英文数据库CNKI、万方和PubMed以及在线网站Baidu和Google Scholar自建库以来发表的降低同种异体血管移植排斥反应的相关文献。中文检索关键词:心血管疾病、内皮细胞、低温冻存、血管移植、免疫原性、排斥反应,同种异体移植和冷冻保护剂;英文检索关键词:cardiovascular disease、endothelial cells、cryopreservation、blood vessel transplantation or vascular graft、Immunogenicity、immune rejection、allograft or allogeneic transplantation or allograft transplantation and cryoprotectant。按照纳入排除标准共选取68篇文献进行综述。结果与结论:①综述发现通过改进现有冷冻技术能够降低同种异体血管移植排斥反应,其中主要涉及冻融方式和冻存保护剂的选择。②现有研究提示冻干法优于低温冻存,但限于条件未能广泛开展,现仍以低温冻存为主,其中玻璃化冻存、缓慢复温和使用不锈钢乃至含银材料效果优于程序式冻存及快速复温。③渗透性和非渗透性冻存保护剂的联合选择,可以在降低其毒性的同时,进一步减少排斥反应的发生。
